Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Zander

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
American Journal of Hematology|June 1, 1994
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiationM A Dimopoulos, J C Yau, S D Huan, et al.
Bone Marrow Transplantation|April 27, 1999
Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 casesW Krüger, B Rüssmann, N Kröger, et al.
Bone Marrow Transplantation|August 16, 2002
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donorsN Kröger, T Zabelina, W Krüger, et al.
Annals of Hematology|June 13, 2001
Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donorsN Kröger, T Zabelina, W Krüger, et al.
Acta Haematologica|February 29, 2000
Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failureN Kröger, C Rauhöft, W Zeller, et al.
Bone Marrow Transplantation|April 8, 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMTP Chevallier, M Labopin, A Nagler, et al.
Leukemia|June 8, 2011
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myelomaN Kröger, T Zabelina, J Berger, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose chemotherapy (CTM) for breast cancerL E Damon, J L Wolf, H S Rugo, et al.
Annals of Hematology|March 22, 2002
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphomaM Hänel, N Kröger, S Sonnenberg, et al.
Journal of Hematotherapy & Stem Cell Research|July 17, 2001
Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantationB Fehse, A Chukhlovin, K Kühlcke, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
American Journal of Hematology|June 1, 1994
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiationM A Dimopoulos, J C Yau, S D Huan, et al.
Bone Marrow Transplantation|April 27, 1999
Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 casesW Krüger, B Rüssmann, N Kröger, et al.
Bone Marrow Transplantation|August 16, 2002
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donorsN Kröger, T Zabelina, W Krüger, et al.
Annals of Hematology|June 13, 2001
Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donorsN Kröger, T Zabelina, W Krüger, et al.
Acta Haematologica|February 29, 2000
Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failureN Kröger, C Rauhöft, W Zeller, et al.
Bone Marrow Transplantation|April 8, 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMTP Chevallier, M Labopin, A Nagler, et al.
Leukemia|June 8, 2011
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myelomaN Kröger, T Zabelina, J Berger, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose chemotherapy (CTM) for breast cancerL E Damon, J L Wolf, H S Rugo, et al.
Annals of Hematology|March 22, 2002
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphomaM Hänel, N Kröger, S Sonnenberg, et al.
Journal of Hematotherapy & Stem Cell Research|July 17, 2001
Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantationB Fehse, A Chukhlovin, K Kühlcke, et al.
Pageof 23